| Thu, Dec 3, 2009 | | • | Should Amgen Buy Human Genome Sciences?
at Forbes.com (Thu, Dec 3)
| | • | A Look Inside Paulson's Investor Letter
at Seeking Alpha (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | • | Calif. insurers say $12 billion invested in Iran
AP (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | • | Protalix shares fall following Pfizer deal
AP (Tue, Dec 1)
| | Mon, Nov 30, 2009 | | • | Experienced Small Cap Portfolio Manager Priced Fair Market Value For IMS Health At $17 To $18 Per Share
Wall Street Transcript (Mon, Nov 30)
| | Sat, Nov 28, 2009 | | • | 12 Years Of Patent Protection For Biologics Based Research And Development Creates Buying Opportunity In Biotech Stocks
Wall Street Transcript (Sat, Nov 28)
| | Fri, Nov 27, 2009 | | • | The fall of the world's best-selling drug
at FT.com (Fri, Nov 27)
| | Tue, Nov 24, 2009 | | • | 3 generations of Wyeths to be sold in NYC
AP (Tue, Nov 24)
| | • | Another Loss for Pfizer in Drug Suits
at The New York Times (Tue, Nov 24)
| | Mon, Nov 23, 2009 | | • | Zeroing In On What's Important
at Forbes.com (Mon, Nov 23)
| | Fri, Nov 20, 2009 | | • | J&J stays true to its diversified model
at FT.com (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | Moody's gives negative view on pharma credit
AP (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | • | FDA panel backs Pfizer's enhanced vaccine for kids
AP (Wed, Nov 18)
| | • | Vaccines on horizon for AIDS, Alzheimer's, herpes
AP (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | • | Vaccines on horizon for AIDS, Alzheimer's, herpes
AP (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | • | New Vaccine Questioned
at The Wall Street Journal Online (Mon, Nov 16)
| | • | Progenics: Are the Prospects That Bad?
at Seeking Alpha (Mon, Nov 16)
| | • | FDA reviews update to Pfizer vaccine for kids
AP (Mon, Nov 16)
| | • | Conn. residents: Pfizer land battle unnecessary
AP (Mon, Nov 16)
| | Fri, Nov 13, 2009 | | • | Grandma knows best when it comes to drugs
at FT.com (Fri, Nov 13)
|
Add WYE News to My Yahoo!:
 
| |
|
0.01% Nasdaq 
0.22%
Headlines
